http://snipurl.com/fuko8  [www_latimes_com] 

(excerpt)

Newer drugs 'safer'

Introduced through the 1990s and early 2000s, the atypical antipsychotics -- 
drugs marketed as Abilify, Seroquel, Zyprexa, Geodon, Clozaril and Risperdal -- 
were widely hailed as superior to older schizophrenia drugs such as Thorazine 
and Haldol, which began to be used in the 1950s and 1960s, respectively. The 
first-generation antipsychotics could be highly effective at taming 
hallucinations and delusions. But some studies indicated that as many as 1 in 5 
who took them developed involuntary tics and muscle movements called tardive 
dyskinesia, a condition that frequently cannot be reversed.

The newer drugs were supposed to be safer and more effective. That claim has 
now been roundly challenged.

A landmark 2005 study concluded that the drugs have brought marginal 
improvements at much greater expense than traditional antipsychotics in their 
primary use of treating schizophrenia. The CATIE study (for Clinical 
Antipsychotic Trials of Intervention Effectiveness) compared four of the 
atypicals -- Zyprexa, Geodon, Seroquel and Risperdal -- with the 
first-generation antipsychotic perphenazine (Trilafon), a drug costing on 
average a tenth the price of the newer drugs. It found the risk of tremors and 
tardive dyskinesia to be the same for all. And while all the antipsychotics are 
associated with weight gain, it was more frequent and more likely to be extreme 
among patients taking atypicals -- leading many to develop diabetes.

Last December, the British journal Lancet published a comprehensive analysis 
that further punctured the new drugs' claims to superiority. A separate study 
found Seroquel by many measures to be no more effective in treatment of 
schizophrenia symptoms than Haldol. And a 2008 study on Abilify found it was 
little better at banishing depressive symptoms than a placebo.

"The results are extremely unimpressive," said Dr. Daniel Carlat, a 
Massachusetts psychiatrist who publishes a respected monthly report on 
psychiatric research. "They just squeak by."


Reply via email to